Navigation Links
Laser Used to Blast Away Cells Causing Irregular Heartbeat
Date:5/27/2010

Treatment worked in people and pigs in study, but more research needed

THURSDAY, May 27 (HealthDay News) -- A new approach to treating irregular heartbeats appears to have demonstrated success in halting abnormal electrical pulses in both patients and pigs, new research indicates.

In essence, the new intervention -- known as "visually guided laser-balloon catheter" -- enables doctors to much more accurately target the so-called "misfiring cells" that emit the irregular electrical impulses that can cause an erratic heartbeat.

In fact, with this new approach, the study team found that physicians could destroy such cells with 100 percent accuracy. This, they said, is due to the procedure's use of a slender medical device called an endoscope, which when inserted into the target region provides a continuous real-time image of the culprit cells.

The traditional means for getting at misfiring cells relies on pre-intervention X-rays for a much less precise snapshot form of visual guidance.

The findings are reported by study author Dr. Vivek Y. Reddy, a senior faculty member in medicine and cardiology at the Mount Sinai Medical Center in New York City, and colleagues in the May 26 online edition of Circulation: Arrhythmia and Electrophysiology.

About 2.2 million Americans currently live with an irregular heartbeat condition, known as atrial fibrillation. Among individuals over the age of 65, it is the most common "serious" form of heart rhythm irregularities, according to background information in a news release from the American Heart Association.

Atrial fibrillation accounts for between 15 percent and 20 percent of all ischemic strokes, with stroke risk rising fivefold among patients with the condition as compared to healthy men and women, the release noted.

The current study focused on 27 patients (66 percent men), all of whom were diagnosed with a form of atrial fibrillation. All had already undergone at least one failed drug regimen.

Reddy's team used the new procedure to successfully blast all the targeted misfiring cells in each patient's pulmonary veins, which transport blood from the lungs to the heart.

The investigators found that after just one laser treatment, misfiring ceased in 84 percent of the treated veins, and 90 percent remained inactive three months after treatment.

The researchers achieved similar results in work with pigs, whose heart closely resembles the structure of the human heart.

More information

For more on irregular heartbeats, visit the U.S. National Library of Medicine.



-- Alan Mozes



SOURCE: American Heart Association, news release, May 25, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Visually guided laser may be viable treatment for abnormal heartbeat
2. New Laser Treatment Offers Revolutionary Response to Aesthetic Procedure Candidates' Number One Concern: Recovery Time
3. New Laser Technology Combined with Manual Physical Therapy Offer Pain Relief to Chronic Pain Sufferers
4. Periowave Dental Technologies Introduces Periowave™ HHL-1000 cordless, Handheld Laser at 2010 Ontario Dental Association Spring Meeting
5. Tattoo Removal Laser Clinic Announces New PhotoAcoustic Laser Technology
6. Kalos: Facial Plastic Surgery Brings the Pearl Fractional Laser to Atlanta
7. Anjolee Receives Stellar Customer Service Award from STELLAService
8. Over 450 Patients Now Toenail Fungus Free Thanks to Your Next Step's New Toenail Fungus Laser Treatment Technology
9. In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics
10. Laser Lipoplasty: Cutting Through the Hype
11. American Laser Centers Offers a Solution for Customers Whose Laser Cosmetic Providers Have Gone Out of Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology: